Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study

Detalles Bibliográficos
Autores principales: Sanz-Linares, Gabriela, Mussetti, Alberto, Albasanz-Puig, Adaia, Salvador-Corre, Iñaki, Sureda, Anna, Gudiol, Carlota, Salazar, Ramon, Marin, Mar, García Martín, Margarita, Navarro, Valentin, De la Haba, Irma, Coma, Eva, Dura, Xavier, Fontanals, Sandra, Serrano, Gala, Cruz, Claudia, Mañez, Rafael, Moreno-González, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665237/
http://dx.doi.org/10.1182/blood-2022-159213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665237/
http://dx.doi.org/10.1182/blood-2022-159213

Ejemplares similares